LHrH(GNrH) Antagonist, Pituitary Suppressant Agents

The phrase "LHrH(GNrH) Antagonist, Pituitary Suppressant Agents" is a compendial and formulary classification representing gonadotropin-releasing hormone receptor antagonists that directly suppress pituitary gonadotropin secretion

The phrase "LHrH(GNrH) Antagonist, Pituitary Suppressant Agents" is a compendial and formulary classification representing gonadotropin-releasing hormone receptor antagonists that directly suppress pituitary gonadotropin secretion

These agents function by competitively binding to pituitary GnRH receptors, which rapidly inhibits the release of luteinizing hormone and follicle-stimulating hormone without inducing the initial hormonal flare associated with agonists Medications in this category, such as cetrorelix, ganirelix, and elagolix, are primarily utilized to prevent premature ovulation during assisted reproductive technology cycles and to manage hormone-dependent gynecologic conditions such as moderate to severe endome...

Medications in this category, such as cetrorelix, ganirelix, and elagolix, are primarily utilized to prevent premature ovulation during assisted reproductive technology cycles and to manage hormone-dependent gynecologic conditions such as moderate to severe endometriosis pain

Medications in this category, such as cetrorelix, ganirelix, and elagolix, are primarily utilized to prevent premature ovulation during assisted reproductive technology cycles and to manage hormone-dependent gynecologic conditions such as moderate to severe endometriosis pain